Patient education: Dilated cardiomyopathy (Beyond the Basics)
- Marilyn Weigner, MD, FACC
Marilyn Weigner, MD, FACC
- Clinical Associate Professor of Medicine
- The Warren Alpert Medical School of Brown University
- James P Morgan, MD, PhD
James P Morgan, MD, PhD
- Professor of Medicine
- Tufts University School of Medicine
DILATED CARDIOMYOPATHY OVERVIEW
Cardiomyopathy is a disease of the heart muscle, or myocardium, that prevents the heart from functioning normally. There are several types of cardiomyopathy, including:
●Arrhythmogenic right ventricular cardiomyopathy
In the United States, dilated cardiomyopathy occurs in approximately five to eight people per 100,000; it causes approximately 10,000 deaths and 46,000 hospitalizations each year. It is the most common reason for heart transplantation.
This topic review discusses the definition, symptoms, diagnosis, and treatment of dilated cardiomyopathy. Hypertrophic cardiomyopathy is discussed separately. (See "Patient education: Hypertrophic cardiomyopathy (Beyond the Basics)".)
Normal heart function — The heart is a pump that contains four chambers: the right atrium, right ventricle, left atrium, and left ventricle (figure 1). Blood returning to the heart from the body flows into the right atrium and then the right ventricle. Blood is pumped out of the right ventricle into the lungs, where oxygen is added. Blood then returns to the heart through the left atrium. Blood in the left atrium flows into the left ventricle, which pumps the blood out the aorta to deliver oxygen to the brain, muscles, and other organs and tissues.
Heart function in dilated cardiomyopathy — Dilated cardiomyopathy (DCM) is a disease of the heart muscle in which the heart chambers become enlarged or dilated (figure 2). The heart muscle is weakened, making it more difficult for blood to flow from the body and lungs into the heart and for blood to be pumped from the heart to the rest of the body. The left ventricle is affected most commonly by DCM, although the right ventricle can also be affected. The dilatation often becomes severe and the heart may become quite enlarged. As the function of the left (and/or right) ventricle worsens, signs and symptoms of heart failure may develop.
The term "heart failure" can be misleading because the heart does not completely fail or stop, but instead functions less effectively. Heart failure may range in severity from a mild condition that causes no symptoms, to one in which the heart muscle is significantly damaged, leaving the person with multiple debilitating symptoms, such as shortness of breath and fatigue at rest. (See "Patient education: Heart failure (Beyond the Basics)".)
CAUSES OF DILATED CARDIOMYOPATHY
Dilated cardiomyopathy (DCM) can be caused by a variety of disorders. In more than 50 percent of cases, however, no cause can be found, and the cardiomyopathy is called "idiopathic."
Some causes of DCM are reversible and the condition improves once the cause is treated or eliminated or the condition subsides. Other causes of DCM produce irreversible damage. In these cases, treatment focuses on optimizing the function of the heart, preventing worsening of heart failure, reducing symptoms, and preventing complications (eg, irregular heartbeat, blood clots). (See 'Dilated cardiomyopathy treatment' below.)
DILATED CARDIOMYOPATHY SYMPTOMS
The most common symptoms of dilated cardiomyopathy (DCM) include the following:
●Shortness of breath (dyspnea) with exertion, which may progress to shortness of breath at rest
●Shortness of breath when lying down (orthopnea)
●Sudden shortness of breath at night, often awakening the patient (paroxysmal nocturnal dyspnea)
●Impaired ability to be active or exercise
●Swelling of the lower legs, ankles, and feet (peripheral edema)
Most people develop symptoms of DCM between the ages of 20 and 60, although it can occur at any age. Symptoms of heart failure typically do not occur until late in the disease. Symptoms may worsen gradually or abruptly appear or worsen.
Often, there are no early symptoms of DCM and the heart is discovered to be enlarged as a result of a test done for another reason (eg, a chest x-ray).
DILATED CARDIOMYOPATHY DIAGNOSIS
The diagnosis and evaluation of dilated cardiomyopathy (DCM) focuses upon determining if there are treatable or reversible causes. This process is described in detail in a separate topic review. (See "Patient education: Heart failure (Beyond the Basics)", section on 'Heart failure diagnosis'.)
Testing of family members — Between 30 and 50 percent of people with idiopathic DCM have inherited a genetic mutation for the disease. Some of these mutations can be identified with blood testing. People who have one or more family members who experienced sudden cardiac death or developed unexplained heart failure before age 60 should be evaluated by a genetics center that is experienced with cardiovascular diseases; a genetics counselor can help to determine if genetic testing would be helpful (see www.nsgc.org; click on "Find a counselor").
If there is no family history of DCM, unexplained heart failure, or sudden cardiac death, first degree family members (eg, parents, siblings, children) of a person with DCM can consider screening tests, including an electrocardiogram and echocardiogram, to determine if there are early signs of DCM. However, there are a few caveats related to screening:
●Screening tests cannot always predict which relatives will be affected by DCM or how severe the disease will be.
●Having a single normal screening test does not mean that cardiomyopathy will not develop in the future. Screening tests are usually repeated every three to five years, unless symptoms develop sooner.
The initial symptoms of DCM are variable (shortness of breath, fainting, sudden death). In people with a family history of DCM, any new symptoms should be evaluated promptly.
DILATED CARDIOMYOPATHY TREATMENT
The treatment of dilated cardiomyopathy (DCM) depends upon the cause, the severity, and whether or not symptoms are present.
Treat the underlying cause — If the cause of DCM can be identified, the first step is to treat this cause. This may include avoiding exposure to toxins (eg, alcohol, cocaine) or treating endocrine disorders (eg, diabetes, thyroid disease).
Treatment of idiopathic DCM — If the cause of DCM is not known (ie, idiopathic DCM), no specific treatment is available. Instead, treatments will be recommended to optimize heart function, reduce the risk of worsening disease, prevent complications, and/or reduce symptoms caused by heart failure.
Treatment of heart failure caused by DCM is the same as that for heart failure caused by other conditions. Treatment of heart failure is discussed in detail in a separate topic review. (See "Patient education: Heart failure (Beyond the Basics)".)
LONG TERM OUTLOOK
The long-term outlook for people with dilated cardiomyopathy depends upon the cause and severity of the heart failure. This is discussed in detail in a separate topic review. (See "Patient education: Heart failure (Beyond the Basics)".)
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient education: Dilated cardiomyopathy (The Basics)
Patient education: Hypertrophic cardiomyopathy in adults (The Basics)
Patient education: Shortness of breath (dyspnea) (The Basics)
Patient education: ECG and stress test (The Basics)
Patient education: Echocardiogram (The Basics)
Patient education: Ventricular premature beats (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Causes of dilated cardiomyopathy
Definition and classification of the cardiomyopathies
Evaluation of the patient with suspected heart failure
Genetics of dilated cardiomyopathy
Overview of the therapy of heart failure with reduced ejection fraction
The following organizations also provide reliable health information.
●National Library of Medicine
●National Heart, Lung, and Blood Institute
●American Heart Association
●Heart Failure Online
(www.heartfailure.org, also available in Spanish)
●European Society of Cardiology
- Jong P, Yusuf S, Rousseau MF, et al. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet 2003; 361:1843.
- Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112:e154.
- Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388.
All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.